PROTOCOL NO.: 02-113 Full Protocol China Project: Metabolism Feasibility Study Revision date March 29, 2002 I.

To: BHRC Communications Committee (E-mail) <benzconsort-cc@api.org>; BHRC Oversight Committee (E-mail) <benzconsort-oc@api.org>; BHRC Technical Committee (E-mail) <benzconsort- tc@api.org>; Shannon Stewart (E-mail)<sstewart@apcoassoc.com> From: Matt Todd <ToddM@api.org> Cc: Bcc: Received Date: 2003-01-0222:18:58 GMT Subject: Shanghai Health Study Update: January 3, 2003 To all Benzene Health Research Consortium Committee Members: Please click on the following link and then go to SHS Update to view this week's update. http://www.shanghaihealthstudy. org Username: Password: If you have any announcements that you would like to include on the website, please contact me at toddm@api.org.

DRAFT September _, 2009 CERTIFIED MAIL - RETURN RECEIPT REQUESTED Document Processing Center (7407M) (Attn: TSCA 8(e) Coordinator) Office of Pollution Prevention and Toxics U.S.

PROGRESS REPORT June, 2004 I.

Benzene Health Research Consortium Technical Committee Dra.ft Minutes Conference Call - 18 Nov 2004 Participants Patrick Beatty (ChevronTexaco) Steve Bose (ExxonMobil) Don Burnett (BP) Stuart Cagen (Shell) Jennifer Galvin (ConocoPhillips) Howard Feldman (API; part-time) Bruce Jarnot (API) Administrative Items Call was conducted in accordance with API antitrust guidelines Agenda: discuss I review "action items" generated at early-November OC meeting in Houston o Expectation to provide update(s) by 10 December 2004 Background Most Action Items can likely be met by PI discussion(s) $3.3MM gap identified by Pis o OC deferred most action items to the TC o Funding required to carry the studies to completion o o Possible BP $1.7MM added contribution?

Excerpted from 11/3/04 minutes: Study budget reanalysis: Approximately $3.3 million of additional funds have been requested by the SHS investigators.

To: benzconsort-tc@ listserve. api. org <benzconsort-tc@ listserve. api. org> From: Bruce Jarnot <jarnotb@api.org> Cc: a.r.schnatter@exxonmobil.com <a.r.schnatter@exxonmobil.com>; yimei.x.zhou@exxonmobil.com <yimei.x.zhou@exxonmobil.com>; thomas.w.armstrong@exxonmobil.com <thomas.w.armstrong@exxonmobil.com> Bcc: Received Date: 2004-12-1014:21:22 GMT Subject: Revised handout (page 4) for today's EA conference call Attached is a revised ppt presentation for this morning's Exposure Assessment conference call.

To: From: Cc: Bcc: Received Date: Subject: Robin Tillery <tilleryr@api.org> Russell White <whiter@api.org> BenzConsort-OC@listserve.api.org <BenzConsort-OC@listserve.api.org> 2007-06-0421 :40:35 GMT FW: MAY 31 BHRC minutes for distribution Robin, Please post to the SHS website.

Benzene Health Research Consortium Exposure Assess 2Q07 Financial Report rdw 10/19/06 RT 8/1/2007 (J) I m r r sI : () () r C ;a G) oI c..n <D c..> ex> (J)

To: From: Cc: Bcc: Received Date: Subject: Cagen, Stuart Z SHLOIL-SHOIL-SHS <stuart.cagen@shell.com>; Clegg, Patsy M SCC-DCS/22 <patsy.clegg@shell.com>; Simpson, Edward J SCC-DCAl2 <Edward.Simpson@shell.com> Methvin, Stacy P SCC-DCA <lO=SHELLlOU=MSXSCC/CN=RECIPIENTS/CN=USSME4> 2007-02-20 02:46:30 GMT RE: Shanghai Health Study - 2007/8 Funding Thanks Stuart, this answers my questions.

that appropriate supporting agreements, including those between API and the five participating companies to increase the funding, would need to be executed as well.

To: Williams, Charlie CR SIEP-EPT-RL <CharlieWiliiams@shell.com> From: Clegg, Patsy M SCC-DCS/22 </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: Bcc: Received Date: 2007-03-2012:59:26 GMT Subject: RE: Shanghai Health Study - Follow-Up Look forward to talking with you on Wed, 11-12.

To: Russell White (E-mail) <whiter@api.org> From: Clegg, Patsy M SCC-DCS/22 </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: Bcc: Received Date: 2007-04-0222:26:51 GMT Subject: BHRC FINAL MINUTES FOR DISTRIBUTION Patsy Clegg Product Steward Shell Chemical LP One Shell Plaza, 91 0 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals Attachments: BHRC call, MAR 152007 Minutes FINAL.ZIP BHRC call, MAR 22 2007 Minutes FINAL.ZIP BHRC call, MAR 6 2007 Minutes FINAL.ZIP BHRC Meeting, MAR 29 2007 Minutes FINAL.ZIP BHRC-API Meetingl , MAR 152007 Minutes FINAL.ZIP SH ELL-MCCLU RG-060462 BHRC OVERSIGHT, TECHNICAL, COMMUNICATIONS COMMITTEES MEETING MINUTES March 29, 2007 Attendees: Anita Balaraman, Chevron Michael Bird, ExxonMobil Steve Bowes, ExxonMobil Don Burnett, BP, part-time Stuart Cagen, Shell Chemical Patsy Clegg (Chair), Shell Chemical Brian Doll, ExxonMobil Howard Feldman, API Mark Fitzsimmons, Steptoe and Johnson Jennifer Galvin, ConocoPhillips, part-time Bob Greco, API Brenda Hargett, API Myron Harrison, ExxonMobil Richard Irons, U of Colorado, part-time Mike Johnston, ConocoPhillips Harry Ng, API Phil Snyder, Shell Chemical John Wagner, API Russell White, API Charlie Williams, API Special Programs Chair, part-time Quorum Present Antitrust Guidelines reviewed Decisions/Actions: 1.

To: From: Cc: Bcc: Received Date: Subject: 'pmclegg@shellus.com' <pmclegg@shellus.com> Paula Podhasky <podhaskyp@api.org> 2000-08-02 17:04: 11 GMT Benzene Epi Mtg Attached please find an invitation to the second planning meeting for the Benzene Epidemiology Consortium.

To: Richard.lrons@UCHSC.edu <Richard.lrons@UCHSC.edu> From: OttoWong@aol.com <OttoWong@aol.com> Cc: Jmricewas@aol.com <Jmricewas@aol.com>; Bruce Jarnot <jarnotb@api.org>; Russell White <whiter@api.org>; michael. g. bi rd @exxonmobil.com <michael. g. bi rd @exxonmobil.com> Bcc: Sent Date: 2007-02-1315:52:34 GMT Subject: Re: Progress report Dear Richard: Based on your email, have you changed your mind and you will no longer provide me with the numbers of AML and lymphoid neoplasm patients to me to fill in my progress report?